Cutanos

Recent Finacing

Equity

Recent Raise

Undisclosed

Cutanos is a Max Planck spin-off developing LC-TDS, a modular transdermal platform using a synthetic ligand to selectively deliver actives to Langerhans cells for vaccines and autoimmune therapies.